Literature DB >> 16498532

The histological appearance of oesophageal adenocarcinoma--an analysis based on 215 resection specimens.

Mario Sarbia1.   

Abstract

The current study was performed to determine whether the histopathological appearance of oesophageal adenocarcinoma (AC) differs significantly from that of cardiac or gastric AC. Therefore, HE-stained slides of 215 primarily resected oesophageal AC, 108 cardiac and 184 gastric AC were classified according to a variety of clinico-pathologic parameters. According to Lauren's classification, oesophageal AC (1.4%) less frequently belonged to the diffuse type than cardiac (2.8%) and gastric AC (23.9%; p<0.0001). Tubular and papillary AC, as defined by the WHO classification, were more frequent among oesophageal (94.4%) than among cardiac (87.0%) and gastric AC (59.2%; p<0.0001). Solid carcinomas, according to Carneiro's classification, were less frequent among oesophageal (2.8%) than among cardiac (10.2%) and gastric AC (9.2%; p<0.0001). Oesophageal AC were graded more frequently G1/G2 (53.9%) than cardiac (30.6%) and gastric AC (27.7%; p<0.0001). Among oesophageal AC, Lauren's classification (p=0.0067), Carneiro's classification (p=0.0170), tumour grade (p=0.0005), lymphatic vessel invasion (p<0.0001) but not WHO classification were histological predictors of postoperative survival. In conclusion, oesophageal AC displays the same histological spectrum as cardiac and gastric AC. However, the relative proportion of differentiated, gland-forming carcinomas is significantly more frequent in the oesophagus than in the cardia and in the stomach.

Entities:  

Mesh:

Year:  2006        PMID: 16498532     DOI: 10.1007/s00428-006-0168-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.

Authors:  S M Dresner; P J Lamb; M K Bennett; N Hayes; S M Griffin
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

3.  Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.

Authors:  Christianne J Buskens; Marinke Westerterp; Sjoerd M Lagarde; Jacques J G H M Bergman; Fiebo J W ten Kate; J Jan B van Lanschot
Journal:  Gastrointest Endosc       Date:  2004-11       Impact factor: 9.427

4.  Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?

Authors:  Valerie W Rusch
Journal:  Semin Oncol       Date:  2004-08       Impact factor: 4.929

5.  Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.

Authors:  R J Kalish; P E Clancy; M B Orringer; H D Appelman
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

6.  Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma.

Authors:  G Heidl; P Langhans; W Mellin; H Bünte; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract.

Authors:  Mario Sarbia; Helene Geddert; Bodo Klump; Sybille Kiel; Erol Iskender; Helmut Erich Gabbert
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

8.  Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinomas of the esophagus.

Authors:  M Sarbia; R Porschen; F Borchard; O Horstmann; R Willers; H E Gabbert
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

9.  Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.

Authors:  Philippe Taniere; Giovanna Borghi-Scoazec; Jean-Christophe Saurin; Catherine Lombard-Bohas; Jean Boulez; Françoise Berger; Pierre Hainaut; Jean-Yves Scoazec
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

10.  Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency.

Authors:  H H Wang; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1986-05       Impact factor: 3.466

View more
  2 in total

1.  EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Authors:  Helene Geddert; Axel zur Hausen; Helmut E Gabbert; Mario Sarbia
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

2.  The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma.

Authors:  D J Crull; M C H Hogenes; R Hoekstra; E M Hendriksen; M J van Det; E A Kouwenhoven
Journal:  Ann Surg Oncol       Date:  2022-01-29       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.